Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03029845 · ClinicalTrials.gov registry record · Phase 1
Propranolol for Treating Fibromyalgia Pain
A Phase 1 study, sponsored by University of Utah.
- Terminated
- Registry status
- Phase 1
- Development phase
- 15
- Enrollment target
NCT03029845 is a Phase 1 study that was terminated before completion, run by University of Utah. The registered enrollment target is 15 participants.
The verdict
NCT03029845, a Phase 1 study, was terminated before completion, sponsored by University of Utah.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 15 participants
- Enrollment target
Study Summary
The purpose of the study to evaluate the feasibility of using low dose propranolol for people with fibromyalgia.
Interventions
- DRUG Placebo
- DRUG Propranolol 1
- DRUG Propranolol 2
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2017-01 |
| Est. Completion | 2018-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03029845
The ClinicalTrials.gov registry entry for NCT03029845 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT03029845 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03029845 about?
NCT03029845 is a clinical study titled "Propranolol for Treating Fibromyalgia Pain". The purpose of the study to evaluate the feasibility of using low dose propranolol for people with fibromyalgia.
What is the current status of trial NCT03029845?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 15 participants. The study started on 2017-01. Estimated completion is 2018-07.
What interventions are being tested in trial NCT03029845?
The interventions under investigation include: Placebo (DRUG), Propranolol 1 (DRUG), Propranolol 2 (DRUG).
Who is sponsoring clinical trial NCT03029845?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.